Filing Details

Accession Number:
0001209191-23-030796
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-18 18:31:30
Reporting Period:
2023-05-16
Accepted Time:
2023-05-18 18:31:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1607678 Viking Therapeutics Inc. VKTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1383292 Jr A Charles Rowland C/O Viking Therapeutics, Inc.
9920 Pacific Heights Blvd, Suite 350
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.00001 Per Share Acquisiton 2023-05-16 40,000 $1.08 70,000 No 4 M Direct
Common Stock, Par Value $0.00001 Per Share Disposition 2023-05-16 40,000 $25.00 30,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-05-16 40,000 $0.00 40,000 $1.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-07-01 2027-07-01 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.